BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/21/2023 8:56:38 AM | Browse: 77 | Download: 150
 |
Received |
|
2023-05-06 10:44 |
|
Peer-Review Started |
|
2023-05-06 10:46 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-05-21 08:09 |
|
Revised |
|
2023-06-23 21:17 |
|
Second Decision |
|
2023-08-08 02:53 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2023-08-08 07:32 |
|
Articles in Press |
|
2023-08-08 07:32 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2023-08-06 03:21 |
|
Typeset the Manuscript |
|
2023-08-16 02:14 |
|
Publish the Manuscript Online |
|
2023-08-21 08:56 |
| ISSN |
1949-8462 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Review |
| Article Title |
Proton pump inhibitors and gastroprotection in patients treated with antithrombotic drugs: A cardiologic point of view
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Maurizio Giuseppe Abrignani, Alberto Lombardo, Annabella Braschi, Nicolò Renda and Vincenzo Abrignani |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Maurizio Giuseppe Abrignani, MD, Doctor, Operative Unit of Cardiology, P. Borsellino Hospital, ASP Trapani, 175 Via Salemi, Marsala 91025, Trapani, Italy. maur.abri@alice.it |
| Key Words |
Antithrombotic drugs; Anticoagulants; Aspirin; Clopidogrel; Gastrointestinal bleeding; Proton pump inhibitors |
| Core Tip |
Antiplatelet and anticoagulant drugs are used across a wide spectrum of cardio-cerebrovascular diseases, but they are related to relatively frequent gastrointestinal bleeding complications, thus requiring a concomitant proton pump inhibitor (PPI) treatment. On the other hand, a potential increased cardiovascular risk has been suggested in patients treated with PPIs. Current guidelines recommend PPI use in combination with antiplatelet treatment in patients with risk factors for gastrointestinal bleeding. In patients taking oral anticoagulant with risk factors for gastrointestinal bleeding, PPIs could also be recommended, even if their usefulness deserves further data. The present review summarizes the current knowledge on this topic. |
| Publish Date |
2023-08-21 08:56 |
| Citation |
Abrignani MG, Lombardo A, Braschi A, Renda N, Abrignani V. Proton pump inhibitors and gastroprotection in patients treated with antithrombotic drugs: A cardiologic point of view. World J Cardiol 2023; 15(8): 375-394 |
| URL |
https://www.wjgnet.com/1949-8462/full/v15/i8/375.htm |
| DOI |
https://dx.doi.org/10.4330/wjc.v15.i8.375 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
